Skip to Main content
Number of documents

62

José Courty


Journal articles60 documents

  • Fabio Raineri, Sandrine Bourgoin-Voillard, Mélissande Cossutta, Damien Habert, Matteo Ponzo, et al.. Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma. Cancers, MDPI, 2021, 13 (12), pp.2986. ⟨10.3390/cancers13122986⟩. ⟨hal-03262175⟩
  • Auriane Maïza, Nazha Sidahmed-Adrar, Patrick Michel, Gilles Carpentier, Damien Habert, et al.. 3-O-sulfated heparan sulfate interactors target synaptic adhesion molecules from neonatal mouse brain and inhibit neural activity and synaptogenesis in vitro. Scientific Reports, Nature Publishing Group, 2020, 10 (1), pp.19114. ⟨10.1038/s41598-020-76030-4⟩. ⟨hal-03023118⟩
  • José Courty. 3-O-sulfated heparan sulfate interactors target synaptic adhesion molecules from neonatal mouse brain and inhibit neural activity and synaptogenesis in vitro. Science Reports of the Tohoku University, 2020. ⟨hal-03016777⟩
  • Sabrina Belbekhouche, Jalal Poostforooshan, Masoom Shaban, Benedetta Ferrara, Vanessa Alphonse, et al.. Fabrication of large pore mesoporous silica microspheres by salt-assisted spray-drying method for enhanced antibacterial activity and pancreatic cancer treatment. International Journal of Pharmaceutics, Elsevier, 2020, 590, pp.119930. ⟨10.1016/j.ijpharm.2020.119930⟩. ⟨hal-03032698⟩
  • Jalal Poostforooshan, Sabrina Belbekhouche, Masoom Shaban, Vanessa Alphonse, Damien Habert, et al.. Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents. ACS Applied Materials & Interfaces, Washington, D.C. : American Chemical Society, 2020, 12 (6), pp.6885-6898. ⟨10.1021/acsami.9b20510⟩. ⟨hal-03032690⟩
  • Kenneth Ramos, Sara Moore, Isabel Runge, Marco Tavera-Garcia, Ilaria Cascone, et al.. The Nucleolin Antagonist N6L Inhibits LINE1 Retrotransposon Activity in Non-Small Cell Lung Carcinoma Cells. American Journal of Cancer, Adis, 2020, 11 (3), pp.733-740. ⟨10.7150/jca.37776⟩. ⟨hal-03032686⟩
  • Sabrina Belbekhouche, Mélissande Cossutta, Damien Habert, Séna Hamadi, Tina Modjinou, et al.. N6L-functionalized nanoparticles for targeted and inhibited pancreatic cancer cells. Colloids and Surfaces A: Physicochemical and Engineering Aspects, Elsevier, 2020, 607, pp.125461. ⟨10.1016/j.colsurfa.2020.125461⟩. ⟨hal-03116693⟩
  • Marie Darche, Mélissande Cossutta, Laure Caruana, Claire Houppe, Maud‐emmanuelle Gilles, et al.. Antagonist of nucleolin, N6L, inhibits neovascularization in mouse models of retinopathies. FASEB Journal, Federation of American Society of Experimental Biology, 2020, 34 (4), pp.5851-5862. ⟨10.1096/fj.201901876r⟩. ⟨hal-03032684⟩
  • Susann Piehler, Heidi Dähring, Julia Grandke, Julia Göring, Pierre Couleaud, et al.. Iron Oxide Nanoparticles as Carriers for DOX and Magnetic Hyperthermia after Intratumoral Application into Breast Cancer in Mice: Impact and Future Perspectives. Nanomaterials, MDPI, 2020, 10 (6), pp.1016. ⟨10.3390/nano10061016⟩. ⟨hal-03032696⟩
  • Mourad Sanhaji, Julia Göring, Pierre Couleaud, Antonio Aires, Aitziber Cortajarena, et al.. The phenotype of target pancreatic cancer cells influences cell death by magnetic hyperthermia with nanoparticles carrying gemicitabine and the pseudo-peptide NucAnt. Nanomedicine: Nanotechnology, Biology and Medicine, Elsevier, 2019, 20, pp.101983. ⟨10.1016/j.nano.2018.12.019⟩. ⟨hal-03095445⟩
  • Mourad Sanhaji, Julia Göring, Pierre Couleaud, Antonio Aires, Aitziber Cortajarena, et al.. The phenotype of target pancreatic cancer cells influences cell death by magnetic hyperthermia with nanoparticles carrying gemicitabine and the pseudo-peptide NucAnt. Nanomedicine: Nanotechnology, Biology and Medicine, Elsevier, 2019, 20, pp.101983. ⟨10.1016/j.nano.2018.12.019⟩. ⟨hal-02347263⟩
  • Mélissande Cossutta, Marie Darche, Gilles Carpentier, Claire Houppe, Matteo Ponzo, et al.. Weibel-Palade Bodies Orchestrate Pericytes During Angiogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, American Heart Association, 2019, 39 (9), pp.1843-1858. ⟨10.1161/ATVBAHA.119.313021⟩. ⟨hal-02347222⟩
  • Demetra Chatzileontiadou, Aikaterini Tsika, Zoi Diamantopoulou, Jean Delbe, Josette Badet, et al.. Evidence for Novel Action at the Cell-Binding Site of Human Angiogenin Revealed by Heteronuclear NMR Spectroscopy, in silico and in vivo Studies. ChemMedChem, Wiley-VCH Verlag, 2018, 13 (3), pp.259-269. ⟨10.1002/cmdc.201700688⟩. ⟨hal-02347346⟩
  • A. de Cola, M. Franceschini, A. Di Matteo, G. Colotti, R. Celani, et al.. N6L pseudopeptide interferes with nucleophosmin protein-protein interactions and sensitizes leukemic cells to chemotherapy. Cancer Letters, Elsevier, 2018, 412, pp.272-282. ⟨10.1016/j.canlet.2017.10.038⟩. ⟨hal-02350445⟩
  • Anne-Chloé Dhez, Elisabetta Benedetti, Andrea Antonosante, Gloria Panella, Brigida Ranieri, et al.. Targeted therapy of human glioblastoma via delivery of a toxin through a peptide directed to cell surface nucleolin. Journal of Cellular Physiology, Wiley, 2018, 233 (5), pp.4091-4105. ⟨10.1002/jcp.26205⟩. ⟨hal-02350449⟩
  • N Jain, H Zhu, T Khashab, Q Ye, B. George, et al.. Targeting nucleolin for better survival in diffuse large B-cell lymphoma. Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2018, 32 (3), pp.663-674. ⟨10.1038/leu.2017.215⟩. ⟨hal-02350480⟩
  • Sarah Lemonnier, Thibault Bouderlique, Salah Naili, Hélene Rouard, José Courty, et al.. Cell Colonization Ability of a Commercialized Large Porous Alveolar Scaffold. Applied Bionics and Biomechanics, Hindawi, 2017, 2017, pp.8949264. ⟨hal-01663681⟩
  • Zoi Diamantopoulou, Maud-Emmanuelle Gilles, Maha Sader, Mélissande Cossutta, Benoît Vallée, et al.. Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy. Oncotarget, Impact journals, 2017, 8 (52), ⟨10.18632/oncotarget.21441⟩. ⟨hal-02061384⟩
  • Damien Destouches, Maha Sader, Stephane Terry, Charles Marchand, Pascale Maillé, et al.. Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer. Oncotarget, Impact journals, 2016, 7 (43), ⟨10.18632/oncotarget.8043⟩. ⟨hal-02350496⟩
  • Gilles Gilles, Federica Maione, Mélissande Cossutta, Gilles Carpentier, Laure Caruana, et al.. Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature. Cancer Research, American Association for Cancer Research, 2016, 76 (24), pp.7181-7193. ⟨10.1158/0008-5472.CAN-16-0300⟩. ⟨hal-02262283⟩
  • F. Morfoisse, F. Tatin, F. Hantelys, A. Adoue, A.-C. Helfer, et al.. Nucleolin Promotes Heat Shock-Associated Translation of VEGF-D to Promote Tumor Lymphangiogenesis. Cancer Research, American Association for Cancer Research, 2016, 76 (15), pp.4394-4405. ⟨10.1158/0008-5472.CAN-15-3140⟩. ⟨hal-02294493⟩
  • Marie Regairaz, Fabienne Munier, Hervé Sartelet, Marine Castaing, Virginie Marty, et al.. Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma. American Journal of Pathology, American Society for Investigative Pathology, 2016, 186 (2), pp.435-445. ⟨10.1016/j.ajpath.2015.10.016⟩. ⟨hal-02350500⟩
  • Susanne Kossatz, Julia Grandke, Pierre Couleaud, Alfonso Latorre, Antonio Aires, et al.. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery. Breast Cancer Research, BioMed Central, 2015, 17 (1), ⟨10.1186/s13058-015-0576-1⟩. ⟨hal-02350515⟩
  • Elisabetta Benedetti, Andrea Antonosante, Michele D’angelo, Loredana Cristiano, Renato Galzio, et al.. Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model. Oncotarget, Impact journals, 2015, 6 (39), ⟨10.18632/oncotarget.5990⟩. ⟨hal-02350508⟩
  • Rania Elahouel, Charly Blanc, Gilles Carpentier, Sophie Frechault, Ilaria Cascone, et al.. Pleiotrophin Exerts Its Migration and Invasion Effect through the Neuropilin-1 Pathway. Journal of Mammary Gland Biology and Neoplasia, Springer Verlag (Germany), 2015, 17 (8), pp.613-624. ⟨10.1016/j.neo.2015.07.007⟩. ⟨hal-02350511⟩
  • S. Lemonnier, Thibault Bouderlique, Patricia Albanese, S. Naili, Nathalie Chevallier, et al.. Dynamic mesenchymal stem cells volumic seeding in a commercialized porous ceramic scaffold: a feasibility study. Computer Methods in Biomechanics and Biomedical Engineering, Taylor & Francis, 2014, 17 (S1), pp.4-5. ⟨hal-01081902⟩
  • Hanneke Zoggel, Yamina Hamma-Kourbali, Cécile Galanth, Ali Ladram, Pierre Nicolas, et al.. Antitumor and angiostatic peptides from frog skin secretions. Amino Acids, Springer Verlag, 2012, 42 (1), pp.385-395. ⟨10.1007/s00726-010-0815-9⟩. ⟨hal-01558881⟩
  • Christophe Morin, A. Roumegous, G. Carpentier, V. Barbier-Chassefiere, L. Garrigue-Antar, et al.. Modulation of Inflammation by Cicaderma Ointment Accelerates Skin Wound Healing. Journal of Pharmacology and Experimental Therapeutics, American Society for Pharmacology and Experimental Therapeutics, 2012, 343 (1), pp.115 - 124. ⟨10.1124/jpet.111.188599⟩. ⟨hal-01756693⟩
  • Damien Destouches, Nicolas Page, Yamina Hamma-Kourbali, Valerie Machi, Olivier Chaloin, et al.. A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surface nucleoproteins.. Cancer Research, American Association for Cancer Research, 2011, 71 (9), pp.3296-3305. ⟨10.1158/0008-5472.CAN-10-3459⟩. ⟨hal-00578863⟩
  • Diala El Khoury, Damien Destouches, Renée Lengagne, Bernard Krust, Yamina Hamma-Kourbali, et al.. Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice.. BMC Cancer, BioMed Central, 2010, 10 (1), pp.325. ⟨10.1186/1471-2407-10-325⟩. ⟨inserm-00668215⟩
  • Isabelle Martelly, Dominique Singabraya, Aurélie Vandebrouck, Dulce Papy-Garcia, Christian Cognard, et al.. Glycosaminoglycan mimetics trigger IP3-dependent intracellular calcium release in myoblasts.. Matrix Biology, Elsevier, 2010, 29 (4), pp.317-29. ⟨10.1016/j.matbio.2010.02.002⟩. ⟨hal-00563747⟩
  • Sophie Besse, François Boucher, Gilberte Linguet, Laurent Riou, Joël de Leiris, et al.. Intramyocardial protein therapy with vascular endothelial growth factor (VEGF-165) induces functional angiogenesis in rat senescent myocardium.. Journal of Physiology and Pharmacology, Krakow Polish Physiological Society, 2010, 61 (6), pp.651-61. ⟨hal-00688199⟩
  • Brigitte Blondet, Gilles Carpentier, Arnaud Ferry, Arnaud Chatonnet, José Courty. Localization of butyrylcholinesteraseat the neuromuscular junction of normal and acetylcholinesterase knockout mice. Journal of Histochemistry and Cytochemistry, Histochemical Society, 2010, 58 (12), pp.1075-1082. ⟨10.1369/jhc.2010.956623⟩. ⟨hal-02665164⟩
  • Nicolas Illy, Laurent Bacri, Justyna Wojno, Damien Destouches, Blandine Brissault, et al.. Unexpected Interactions of an Alternating Poly(ether-ester) with Artificial and Biological Bilipidic Membranes. Macromolecular Symposia, Wiley-VCH Verlag, 2010, 287 (1), pp.60-68. ⟨10.1002/masy.201050109⟩. ⟨hal-02006536⟩
  • Christine Le Page, Philippe Noirez, José Courty, Bruno Riou, Bernard Swynghedauw, et al.. Exercise training improves functional post-ischemic recovery in senescent heart. Experimental Gerontology, Elsevier, 2009, 44 (3), pp.177. ⟨10.1016/j.exger.2008.10.003⟩. ⟨hal-00493089⟩
  • Veronique Friand, Oualid Haddad, Dulce Papy-Garcia, Hanna Hlawaty, Roger Vassy, et al.. Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells.. Glycobiology, Oxford University Press (OUP), 2009, 19 (12), pp.1511-24. ⟨10.1093/glycob/cwp130⟩. ⟨pasteur-00415323⟩
  • Ammar Achour, Jean Pierre M'Bika, Françoise Baudouin, Danièle Caruelle, José Courty. Pleiotrophin induces expression of inflammatory cytokines in peripheral blood mononuclear cells.. Biochimie, Elsevier, 2008, epub ahead of print. ⟨10.1016/j.biochi.2008.04.010⟩. ⟨hal-00319805⟩
  • Damien Destouches, Diala El Khoury, Yamina Hamma-Kourbali, Bernard Krust, Patricia Albanese, et al.. Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin.. PLoS ONE, Public Library of Science, 2008, 3 (6), pp.e2518. ⟨10.1371/journal.pone.0002518⟩. ⟨hal-00294100⟩
  • Aurélie Ducès, Racha Karaky, Dominique Martel-Renoir, Ivan Biéche, Paule Opolon, et al.. The 16-kDa fragment of pleiotrophin acts on endothelial and mammalian tumor cells and inhibits breast tumor development. Molecular Cancer Therapeutics, American Association for Cancer Research, 2008, pp.00. ⟨hal-00315907⟩
  • Yamina Hamma-Kourbali, Isabelle Bernard-Pierrot, Mélanie Heroult, Sophie Dalle, Danièle Caruelle, et al.. Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain.. Journal of Cellular Physiology, Wiley, 2008, 214 (1), pp.250-9. ⟨10.1002/jcp.21191⟩. ⟨hal-00172751⟩
  • Oya Bermek, Zoi Diamantopoulou, Apostolis Polykratis, Celia dos Santos, Yamina Hamma-Kourbali, et al.. A basic peptide derived from the HARP C-terminus inhibits anchorage-independent growth of DU145 prostate cancer cells.. Experimental Cell Research, Elsevier, 2007, 313 (19), pp.4041-4050. ⟨hal-00425379⟩
  • Oya Bermek, Zoi Diamantopoulou, Apostolis Polykratis, Celia dos Santos, Yamina Hamma-Kourbali, et al.. A basic peptide derived from the HARP C-terminus inhibits anchorage-independent growth of DU145 prostate cancer cells.. Experimental Cell Research, Elsevier, 2007, 313 (19), pp.4041-50. ⟨10.1016/j.yexcr.2007.07.032⟩. ⟨hal-00319846⟩
  • Said Charef, Emmanuel Petit, Denis Barritault, José Courty, Jean-Pierre Caruelle. Effects on coagulation of a synthetic heparan mimetic given intraperitoneally or orally.. Journal of Biomedical Materials Research Part A, Wiley, 2007, epub ahead of print. ⟨10.1002/jbm.a.31385⟩. ⟨hal-00172752⟩
  • Richard A Dean, Georgina S Butler, Yamina Hamma-Kourbali, Jean Delbé, David R Brigstock, et al.. Identification of Candidate Angiogenic Inhibitors Processed by MMP-2 in Cell Based Proteomic Screens: Disruption of VEGF/HARP (Pleiotrophin) and VEGF / CTGF Angiogenic Inhibitory Complexes by MMP-2 Proteolysis.. Molecular and Cellular Biology, American Society for Microbiology, 2007, epub ahead of print. ⟨10.1128/MCB.00821-07⟩. ⟨hal-00187899⟩
  • Angela Sutton, Veronique Friand, Dulce Papy-Garcia, Maylis Dagouassat, Loïc Martin, et al.. Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells.. Molecular Cancer Therapeutics, American Association for Cancer Research, 2007, 6 (11), pp.2948-58. ⟨10.1158/1535-7163.MCT-07-0114⟩. ⟨hal-00195453⟩
  • Oya Bermek, Zoi Diamantopoulou, Apostolis Polykratis, Celia dos Santos, Yamina Hamma-Kourbali, et al.. A basic peptide derived from the HARP C-terminus inhibits anchorage-independent growth of DU145 prostate cancer cells.. Experimental Cell Research, Elsevier, 2007, 313 (19), pp.4041-4050. ⟨10.1016/j.yexcr.2007.07.032⟩. ⟨hal-00172750⟩
  • José Courty, M. Hatziapostolou, M. Polytarchou, P. Katsoris, E. Papadimitriou. Heparin affin regulatory peptide/pleiotrophin mediates fibroblast growth factor 2 stimulatory effects on human prostate cancer cells.. Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2006, 281 (43), pp.32217-32226. ⟨hal-00109602⟩
  • José Courty, D. Boerboom, Ld White, S. Dalle, Js Richards. Dominant-stable beta-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model.. Cancer Research, American Association for Cancer Research, 2006, 66 (4), pp.1964-1973. ⟨hal-00109604⟩
  • José Courty, G. Kokolakis, C. Mikelis, E. Papadimitriou, E. Karetsou, et al.. Effect of heparin affin regulatory peptide on the expression of vascular endothelial growth factor receptors in endothelial cells. In Vitro Cellular & Developmental Biology - Animal, Springer, 2006, in press. ⟨hal-00109747⟩
  • Jose Courty, B. Blondet, G. Carpentier, A. Ferry. Exogenous pleiotrophin applied to lesioned nerve impairs muscle reinnervation.. Neurochemical research., 2006, 31 (7), pp.907-913. ⟨hal-00109603⟩
  • Elias A Said, José Courty, Josette Svab, Jean Delbé, Bernard Krust, et al.. Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin.. FEBS Journal, Wiley, 2005, 272 (18), pp.4646-59. ⟨10.1111/j.1742-4658.2005.04870.x⟩. ⟨hal-00104912⟩
  • Christophe Morin, Roland Zini, Jean-Paul Tillement, Aldo Bertelli, Alberto A.E Bertelli, et al.. Molecular Properties and Pharmacokinetic Behavior of Cetirizine, a Zwitterionic H 1 -Receptor Antagonist. Journal of Medicinal Chemistry, American Chemical Society, 1998, 41 (6), pp.853 - 863. ⟨10.1021/jm9704311⟩. ⟨hal-01756670⟩
  • M Perderiset, J. Courty, A. Mereau, E. Chevet, D. Barritault. Purification of a heparin binding FGF receptor (HB-FGFR) from adult bovine brain membranes.. Biochimie, Elsevier, 1992, 74 (12), pp.1091-6. ⟨hal-02201595⟩
  • Agnes Mereau, Mylène Perderiset, Dominique Ledoux, Isabelle Pieri, José Courty, et al.. Isolation of Basic FGF Receptors from Adult Bovine Brain Membranes. Annals of the New York Academy of Sciences, Wiley, 1991, 638 (1 The Fibroblas), pp.394-396. ⟨10.1111/j.1749-6632.1991.tb49050.x⟩. ⟨hal-02201470⟩
  • Dominique Ledoux, Agnes Mereau, Mickael Jaye, Marcelle Miskulin, Denis Barritault, et al.. Adult Brain but Not Kidney, Liver, Lung, Intestine, and Stomach Membrane Preparations Contain Detectable Amounts of High-Affinity Receptors to Acidic and Basic Growth Factors. Annals of the New York Academy of Sciences, Wiley, 1991, 638 (1 The Fibroblas), pp.397-399. ⟨10.1111/j.1749-6632.1991.tb49051.x⟩. ⟨hal-02201475⟩
  • D Ledoux, A. Mereau, I Pieri, D. Barritault, J Courty. High affinity receptors to acidic and basic fibroblast growth factor (FGF) are detected mainly in adult brain membrane preparations but not in liver, kidney, intestine, lung or stomach.. Growth Factors, Taylor & Francis, 1991, 5 (3), pp.221-31. ⟨hal-02201473⟩
  • Dominique Ledoux, Agnès Méreau, Marie Claude Dauchel, Denis Barritault, José Courty. Distribution of basic fibroblast growth factor binding sites in various tissue membrane preparations from adult guinea pig. Biochemical and Biophysical Research Communications, Elsevier, 1989, 159 (1), pp.290-296. ⟨10.1016/0006-291x(89)92436-4⟩. ⟨hal-02201378⟩
  • D. Dauchel, J. Courty, A. Mereau, D. Barritault, M. Dauchel. Modulation of mitogenic activity and cellular binding of basic fibroblast growth factor by basic proteins. Journal of Cellular Biochemistry, Wiley, 1989, 39 (4), pp.411-420. ⟨10.1002/jcb.240390407⟩. ⟨hal-02201385⟩
  • A. Mereau, I. Pieri, C. Gamby, J. Courty, D. Barritault. Purification of basic fibroblast growth factor receptors from bovine brain.. Biochimie, Elsevier, 1989, 71 (7), pp.865-71. ⟨hal-02201387⟩
  • J. Courty, D. Dauchel, A. Mereau, J. Badet, D. Barritault. Presence of basic fibroblast growth factor receptors in bovine brain membranes.. Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 1988, 263 (23), pp.11217-20. ⟨hal-02201376⟩

Conference papers1 document

  • S. Lemonnier, Thibault Bouderlique, Patricia Albanese, S. Naili, Nathalie Chevallier, et al.. Dynamic mesenchymal stem cells volumic seeding in a commercialized porous ceramic scaffold: a feasibility study. 39e Congrès de la Société de Biomécanique, Aug 2014, Valenciennes, France. pp.4-5. ⟨hal-01167305⟩

Book sections1 document

  • Michel Moenner, Josette Badet, Bruno Chevallier, M Tardieu, J. Courty, et al.. Eye-derived fibroblast growth factors: receptors and early events studies. Daniel B. Rifkin,‎ Michael Klagsbrun. Angiogenesis, mechanisms and pathobiology, Cold Spring Harbor Laboratory Press, pp.52-57, 1987, Current Communications in Molecular Biology, 978-0879693008. ⟨hal-01640503⟩